Inventory shock masks growth; recovery expected H2 if geopolitics hold
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Jodhpur timeline on track, inventory accounting explanation credible, margin recovery claims unproven. Avoids numeric guidance.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Revenue +15% YoY but PAT -47% due to inventory accounting shock now passing. Management credibly frames Q2 as temporary; October recovery narrative is early-stage. Jodhpur ramp real but risk of crude volatility and price-hike volume elasticity unproven.
₹358.8 Cr
Revenue · +15% YoY₹13.4 Cr
Reported PAT · −47% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Gross margin collapsed 660 bps due to high-cost raw material inventory expensed in Q2
METQ2 gross margin 38.5% vs 45.1% PY = 660 bps decline. Inventory impact acknowledged; H1 margin 41.9% vs 45.6% = 370 bps (cleaner view).
Stand-alone revenue growth 14.1% YoY in Q2; industry grew 12-14%
METConsolidated Q2 revenue 358.7 Cr (+15% YoY per call, +15% per delivered). Marginal industry outperformance claimed.
October 2026 record sales, highest Y-on-Y monthly growth in 3-4 years
UnverifiedStated on call post-Q2 close (Nov 2). Not verified in Q2 results.
Jodhpur water-based plant will be fully operational by end of November 2026
METTrial production started late Sept; expects declaration of trial completion by end-Nov, definitely Dec. Concrete timeline but slightly fuzzy.
No future profitability shocks expected from Q3 onwards as inventory is behind us
OVERSTATEDContingent on raw material price stability (crude at $110-115). If geopolitical flare-up repeats, volatility returns. Acknowledged as beyond control.
Earnings quality
What changed since the last call
Inventory burden now visible; prior call vague
DowngradeQ1 FY27 benefited from low-cost inventory (EBITDA +42% YoY). Q2 reversed (-33% YoY) as high-cost stock expensed. No prior call predicted this swing.
October record sales claimed post-close
UpgradeStated on this call (Nov 2) that Oct had highest-ever monthly sales + Y-on-Y growth. Not in prior guidance but early signal of H2 recovery.
Guidance stance unchanged; no numeric targets
NeutralPrior call: no formal FY27 target, aggressive growth + margin compression. This call: same narrative, no number guidance ('I hesitate to give a number').
The Q&A
Analysts pressed hard on 3 themes: (1) gross margin breakdown (Kapadia got detailed inventory explanation), (2) sustainability of growth claims (Roy challenged 2x-3x industry language), (3) recovery credibility (Akhilesh B pushed on demand elasticity to price hikes). Management held firm on inventory-as-anomaly but dodged number guidance, citing geopolitical risk.
H2 margin recovery expectations — Abneesh Roy, Nuvama
AnsweredIf industry grows 12-15% in Q3 and we can do 23-25%, margins should improve substantially. Q4 historical precedent: EBITDA 23%, so 'not very pessimistic'.
Competitive dynamics and market share — Abneesh Roy, Nuvama
PartialLocal player data unpublished. Industry leader tends to gain disproportionately on price hikes. Competitors recovering ground now. 'Slightly weak base' of prior 2 years helps industry leader bounce.
Inventory and margin breakdown — Prakash Kapadia, Entrust
AnsweredProduct mix (premiums weak in Q2 monsoon) accounts ~2.5%, raw material inventory accounts ~4%. Q3 mix recovers, inventory clears by Aug, margins normalize. Not expecting repeat.
Water plant timeline and trial completion — Deepak Juneja, Individual
AnsweredTrial started late Sept. No permissions awaited (pollution, factory license, electric all in place). End-Nov target to declare trials over, definitely operational by Dec. Day-by-day debugging ongoing.
Raw material volatility and future shocks — Deepak Juneja, Individual
AnsweredHigh-cost inventory already expensed in Aug. Crude now $110-115 stable. If crude goes up again, yes, could repeat. Hedging options not available for paint raw materials. Manage via inventory.
Price hike absorption and volume elasticity — Aniruddha Joshi, ICICI
AnsweredPrice hikes dictated by industry leader. Timing/magnitude determined by leader, not followers. Inflation does not cover exact products. Demand historically inelastic to paint price (labor >55% of paint cost). No adverse volume impact seen so far.
Demand trends and market sentiment — Akhilesh B, Northstar
AnsweredDemand elasticity historically weak (paint is non-discretionary; bought once in 3-4 years). Prices flat for 2-3 years before this year's hikes. Demand recovery started post-Diwali 2025, accelerating. Not expecting margin headwind from demand.
Growth initiative details and competitive measures — Akhilesh B, Northstar
PartialMost initiatives confidential. Not just discounting (small part). Includes influencer engagement with painters/contractors, higher A&P spend (reflect in Q2 +1% of sales). Results to show in Q3-Q4.
Jodhpur plant capex and double-digit growth — Uchit Garg, Individual
AnsweredJodhpur new plant 90KL, modern with automation. More capacity than old plant, automation not present before. Even at 'best case' top-line growth, won't need major capex next 2-3 yrs. Capacity utilization peaks ~75% Oct, drops ~50-55% off-season, ~60% average. No constraint.
Raw material hedging strategy — Uchit Garg, Individual
AnsweredHedging options not available for paint raw materials (unlike copper/aluminum). Not commodities like that. Forward buying not possible. Manage via inventory and pricing discipline.
Guidance
No formal FY27 revenue target. Pursuing aggressive top-line growth 2x-3x industry growth.
LowHemant explicitly states 'I hesitate to give a number guidance.' Aspiration is 2x-3x but depends on industry growth (expects 12-15% in Q3). No FY27 end-target stated.
Gross margins to improve 'substantially' from Q3 onwards. EBITDA margins to 'normalize' H2.
MediumHigh-cost inventory cleared by Aug; pass-through complete by Sept per call. Price hikes implemented/planned in Nov. Conditions: crude stable, no new raw material shocks.
Jodhpur plant ₹275 Cr spend (major capex now complete). No material capex required for next 2-3 years post-Jodhpur.
HighNew plant 90KL capacity with automation eliminates need for major expansion. South India plant (commissioned 3 yrs ago) has excess capacity. Adequate for dual-digit growth.
Risks the call surfaced
Raw material volatility
HighCrude has spiked twice (March-April 2026 +doubling, July-Aug climb). No forward buying or hedging available for paint raw materials. Q2 inventory shock shows pass-through lag.
Volume elasticity to price hikes
MediumTwo price hikes announced in Nov (+10-12% total from March). Management claims demand inelastic (paint <50% of total painting cost), but 3.5 yrs of price stability prior means customer behavior untested at this scale.
Jodhpur plant execution risk
MediumJodhpur trial production started late Sept 2026. Full commercial operation target is end-Nov, but timeline is loose ('end of Nov is when we'll declare trials over; it may happen 10-15 days earlier'). Automation debugging ongoing daily.
Inventory accounting volatility
MediumQ1 benefited from expensing low-cost inventory purchased pre-March (EBITDA +42% YoY anomaly). Q2 reverse: high-cost inventory from March-April got expensed (-33% YoY). Management claims this is 'entirely because of the quirk of accountancy' but it masks operational volatility.
Margin recovery credibility
MediumManagement claims H2 EBITDA margin recovery to 'near normal' but avoids number guidance. Q4 typically strong (23% EBITDA margin historical). But Q3 recovery from -33% EBITDA growth is aggressive claim without quarterly target.
Management
Score 7/10. Clear on inventory mechanics and operational drivers (gross margin, product mix). Transparent about external volatility (geopolitical). Deliberately vague on number guidance ('I hesitate to give a number') to avoid repeat of prior missed targets. Defensive tone but honest. Jodhpur on schedule (trial Sept, full ops end-Nov). Gross margin recovery narrative credible (August recovery mentioned, Oct record sales). But Q2 miss on profitability (-47% PAT) shows execution gap vs market expectations.
1 · Nov-Dec 2026
Jodhpur plant full operational; gross margin stabilization
2 · Q3 FY27 (Oct-Dec)
Festive quarter strength + price hike absorption + inventory normalization
3 · H2 FY27
EBITDA margin recovery; outperformance vs industry if geopolitics stable
Jodhpur ramp real but risk of crude volatility and price-hike volume elasticity unproven.
Informational and educational content only. Not investment advice.